Wave Life Sciences (WVE) Other Working Capital Changes (2014 - 2026)
Wave Life Sciences (WVE) posted Other Working Capital Changes of -$28.2 million for Q1 2026, down 303.72% on a QoQ basis from $13.9 million in Q4 2025, and down 207.86% year-over-year from $26.2 million in Q1 2025.
Wave Life Sciences (WVE) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Wave Life Sciences' Other Working Capital Changes history runs 11 years deep, the most recent figure standing at -$28.2 million for Q1 2026.
- Quarterly Other Working Capital Changes fell 207.86% year-over-year to -$28.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.1 million (up 78.86% YoY) and the FY2024 annual result came in at -$93.6 million, down 49157.37% from the prior year.
- Other Working Capital Changes was -$28.2 million for Q1 2026 at Wave Life Sciences, down from $13.9 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.0 million in Q2 2024 and bottomed at -$6.3 million in Q3 2024.
- A 5-year average of -$1.1 million and a median of $109000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 14467.74% in 2023, while the deepest fall reached 27742.38% in 2023.
- Wave Life Sciences' Other Working Capital Changes stood at $2.2 million in 2022, then sank by 2945.58% to -$62.5 million in 2023, then slumped by 31.74% to -$82.3 million in 2024, then soared by 116.84% to $13.9 million in 2025, then sank by 303.72% to -$28.2 million in 2026.
- Business Quant data shows WVE's Other Working Capital Changes at -$28.2 million in Q1 2026, $13.9 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 751,000.00 |
| Mar 31, 2026 | 751,000.00 |
| Mar 31, 2026 | 751,000.00 |
| Dec 31, 2025 | 452,000.00 |
| Dec 31, 2025 | 452,000.00 |
| Dec 31, 2025 | 452,000.00 |
| Sep 30, 2025 | -4.85 Mn |
| Sep 30, 2025 | -4.85 Mn |
| Sep 30, 2025 | -4.85 Mn |
| Jun 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Mar 31, 2025 | -118,000.00 |
| Mar 31, 2025 | -118,000.00 |
| Mar 31, 2025 | -118,000.00 |
| Dec 31, 2024 | -1.77 Mn |
| Dec 31, 2024 | -1.77 Mn |
| Dec 31, 2024 | -1.77 Mn |
| Sep 30, 2024 | -6.35 Mn |
| Sep 30, 2024 | -6.35 Mn |